Ann: Annual Report and Notice of Annual General Meeting, page-62

I am furious too. My two questions were not answered or acknowledged. Why such a short meeting?
Still feel positive about Biotron’s future re HIV, Hep B and SARS COVID-2.
MM seemed nervous Yes! Is it because it was zoom?
Loved that she did mention close to finalising BIT 010 study re HIV and that these results will be shown to potential partners.
MM suggests that they are working collaboratively with potential partners in selecting small molecules to take to the next trial. It seems they are totally in step with what Big Pharma wants.
MM stated that Biotron HIV results from a paper in Journal of Infectious Diseases is much anticipated by big Pharma and will then be shared.
MM stated - Hep B- progressing to animal studies by Q1 2021, yehhhh!

Finally, loved the fact that HIV compound BIT009 (I think I I .
it was) is not only an antiviral but elicits an immune,vaccine like response. n